Literature DB >> 12381663

Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation.

Seiji Tanaka1, John F X Diffley.   

Abstract

Although genomic instability is a hallmark of human cancer cells, the mechanisms by which genomic instability is generated and selected for during oncogenesis remain obscure. In most human cancers, the pathway leading to the activation of the G1 cyclins is deregulated. Using budding yeast as a model, we show that overexpression of the G1 cyclin Cln2 inhibits the assembly of prereplicative complexes (pre-RCs) and induces gross chromosome rearrangements (GCR). Our results suggest that deregulation of G1 cyclins, selected for in oncogenesis because it confers clonal growth advantage, may also provide an important mechanism for generating genomic instability by inhibiting replication licensing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381663      PMCID: PMC187461          DOI: 10.1101/gad.1011002

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  65 in total

1.  The Cdc4/34/53 pathway targets Cdc6p for proteolysis in budding yeast.

Authors:  L S Drury; G Perkins; J F Diffley
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

2.  Protein kinase inhibition in G2 causes mammalian Mcm proteins to reassociate with chromatin and restores ability to replicate.

Authors:  D Coverley; H R Wilkinson; M A Madine; A D Mills; R A Laskey
Journal:  Exp Cell Res       Date:  1998-01-10       Impact factor: 3.905

Review 3.  Getting started: regulating the initiation of DNA replication in yeast.

Authors:  W M Toone; B L Aerne; B A Morgan; L H Johnston
Journal:  Annu Rev Microbiol       Date:  1997       Impact factor: 15.500

4.  Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase.

Authors:  R Verma; R S Annan; M J Huddleston; S A Carr; G Reynard; R J Deshaies
Journal:  Science       Date:  1997-10-17       Impact factor: 47.728

5.  Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.

Authors:  T G Paulson; A Almasan; L L Brody; G M Wahl
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system.

Authors:  K F Macleod; Y Hu; T Jacks
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

7.  Inactivation of p53 results in high rates of homologous recombination.

Authors:  K L Mekeel; W Tang; L A Kachnic; C M Luo; J S DeFrank; S N Powell
Journal:  Oncogene       Date:  1997-04-17       Impact factor: 9.867

8.  Two steps in the assembly of complexes at yeast replication origins in vivo.

Authors:  J F Diffley; J H Cocker; S J Dowell; A Rowley
Journal:  Cell       Date:  1994-07-29       Impact factor: 41.582

9.  ORC- and Cdc6-dependent complexes at active and inactive chromosomal replication origins in Saccharomyces cerevisiae.

Authors:  C Santocanale; J F Diffley
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

Review 10.  Genetic instability as a consequence of inappropriate entry into and progression through S-phase.

Authors:  A Almasan; S P Linke; T G Paulson; L C Huang; G M Wahl
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

View more
  68 in total

1.  Cdk1-interacting protein Cip1 is regulated by the S phase checkpoint in response to genotoxic stress.

Authors:  Ze Zhang; Ping Ren; Ajay A Vashisht; James A Wohlschlegel; David G Quintana; Fanli Zeng
Journal:  Genes Cells       Date:  2017-08-03       Impact factor: 1.891

2.  Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in Saccharomyces cerevisiae.

Authors:  Stephanie Smith; Ji-Young Hwang; Soma Banerjee; Anju Majeed; Amitabha Gupta; Kyungjaem Myung
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

Review 3.  Regulation of the initiation step of DNA replication by cyclin-dependent kinases.

Authors:  Seiji Tanaka; Hiroyuki Araki
Journal:  Chromosoma       Date:  2010-08-05       Impact factor: 4.316

4.  Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycle.

Authors:  S J Orr; T Gaymes; D Ladon; C Chronis; B Czepulkowski; R Wang; G J Mufti; E M Marcotte; N S B Thomas
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

Review 5.  Genomic instability and cancer: lessons learned from human papillomaviruses.

Authors:  Nina Korzeniewski; Nicole Spardy; Anette Duensing; Stefan Duensing
Journal:  Cancer Lett       Date:  2010-11-13       Impact factor: 8.679

6.  Fork rotation and DNA precatenation are restricted during DNA replication to prevent chromosomal instability.

Authors:  Stephanie A Schalbetter; Sahar Mansoubi; Anna L Chambers; Jessica A Downs; Jonathan Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

7.  Functional connection between the Clb5 cyclin, the protein kinase C pathway and the Swi4 transcription factor in Saccharomyces cerevisiae.

Authors:  Ethel Queralt; J Carlos Igual
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

Review 8.  Genomic instability--an evolving hallmark of cancer.

Authors:  Simona Negrini; Vassilis G Gorgoulis; Thanos D Halazonetis
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

9.  Mitotic checkpoint function in the formation of gross chromosomal rearrangements in Saccharomyces cerevisiae.

Authors:  Kyungjae Myung; Stephanie Smith; Richard D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-28       Impact factor: 11.205

10.  Suppression of gross chromosomal rearrangements by yKu70-yKu80 heterodimer through DNA damage checkpoints.

Authors:  Soma Banerjee; Stephanie Smith; Kyungjae Myung
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.